These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33964283)

  • 1. Randialic acid B and tomentosolic acid block formyl peptide receptor 1 in human neutrophils and attenuate psoriasis-like inflammation in vivo.
    Korinek M; Hsieh PS; Chen YL; Hsieh PW; Chang SH; Wu YH; Hwang TL
    Biochem Pharmacol; 2021 Aug; 190():114596. PubMed ID: 33964283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Garcinia Multiflora Inhibits FPR1-Mediated Neutrophil Activation and Protects Against Acute Lung Injury.
    Tsai YF; Yang SC; Chang WY; Chen JJ; Chen CY; Chang SH; Hwang TL
    Cell Physiol Biochem; 2018; 51(6):2776-2793. PubMed ID: 30562761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Honokiol suppresses formyl peptide-induced human neutrophil activation by blocking formyl peptide receptor 1.
    Liu FC; Yu HP; Syu YT; Fang JY; Lin CF; Chang SH; Lee YT; Hwang TL
    Sci Rep; 2017 Jul; 7(1):6718. PubMed ID: 28751674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propofol inhibits superoxide production, elastase release, and chemotaxis in formyl peptide-activated human neutrophils by blocking formyl peptide receptor 1.
    Yang SC; Chung PJ; Ho CM; Kuo CY; Hung MF; Huang YT; Chang WY; Chang YW; Chan KH; Hwang TL
    J Immunol; 2013 Jun; 190(12):6511-9. PubMed ID: 23670191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive secondary metabolites of a marine Bacillus sp. inhibit superoxide generation and elastase release in human neutrophils by blocking formyl peptide receptor 1.
    Yang SC; Lin CF; Chang WY; Kuo J; Huang YT; Chung PJ; Hwang TL
    Molecules; 2013 Jun; 18(6):6455-68. PubMed ID: 23736784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1.
    Yang SC; Chang SH; Hsieh PW; Huang YT; Ho CM; Tsai YF; Hwang TL
    Free Radic Biol Med; 2017 May; 106():254-269. PubMed ID: 28232203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kan-Lu-Hsiao-Tu-Tan, a traditional Chinese medicine formula, inhibits human neutrophil activation and ameliorates imiquimod-induced psoriasis-like skin inflammation.
    Chiang CC; Cheng WJ; Lin CY; Lai KH; Ju SC; Lee C; Yang SH; Hwang TL
    J Ethnopharmacol; 2020 Jan; 246():112246. PubMed ID: 31539577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propofol inhibits endogenous formyl peptide-induced neutrophil activation and alleviates lung injury.
    Chen CY; Tsai YF; Huang WJ; Chang SH; Hwang TL
    Free Radic Biol Med; 2018 Dec; 129():372-382. PubMed ID: 30312762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting formyl peptide receptor 1 with anteiso-C13-surfactin for neutrophil-dominant acute respiratory distress syndrome.
    Yang SC; Wang YH; Ho CM; Tsai YF; Sung PJ; Lin TE; Hwang TL
    Br J Pharmacol; 2023 Aug; 180(16):2120-2139. PubMed ID: 36929355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists.
    Kirpotina LN; Schepetkin IA; Khlebnikov AI; Ruban OI; Ge Y; Ye RD; Kominsky DJ; Quinn MT
    Biochem Pharmacol; 2017 Oct; 142():120-132. PubMed ID: 28690139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.
    Schepetkin IA; Khlebnikov AI; Kirpotina LN; Quinn MT
    Int Immunopharmacol; 2016 Aug; 37():43-58. PubMed ID: 26382576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AZ2158 is a more potent formyl peptide receptor 1 inhibitor than the commonly used peptide antagonists in abolishing neutrophil chemotaxis.
    Forsman H; Wu Y; Mårtensson J; Björkman L; Granberg KL; Dahlgren C; Sundqvist M
    Biochem Pharmacol; 2023 May; 211():115529. PubMed ID: 37004778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional selective FPR1 signaling in favor of an activation of the neutrophil superoxide generating NOX2 complex.
    Lind S; Dahlgren C; Holmdahl R; Olofsson P; Forsman H
    J Leukoc Biol; 2021 Jun; 109(6):1105-1120. PubMed ID: 33040403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils.
    Maaty WS; Lord CI; Gripentrog JM; Riesselman M; Keren-Aviram G; Liu T; Dratz EA; Bothner B; Jesaitis AJ
    J Biol Chem; 2013 Sep; 288(38):27042-27058. PubMed ID: 23873933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-peptide receptor inhibitor with selectivity for one of the neutrophil formyl peptide receptors, FPR 1.
    Cevik-Aras H; Kalderén C; Jenmalm Jensen A; Oprea T; Dahlgren C; Forsman H
    Biochem Pharmacol; 2012 Jun; 83(12):1655-62. PubMed ID: 22410002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitocryptide-2: Identification of Its Minimum Structure for Specific Activation of FPR2-Possible Receptor Switching from FPR2 to FPR1 by Its Physiological C-terminal Cleavages.
    Marutani T; Nishino K; Miyaji T; Kamada K; Ohura K; Kiso Y; Mukai H
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones.
    Schepetkin IA; Kirpotina LN; Khlebnikov AI; Cheng N; Ye RD; Quinn MT
    Biochem Pharmacol; 2014 Dec; 92(4):627-41. PubMed ID: 25450672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library.
    Forsman H; Kalderén C; Nordin A; Nordling E; Jensen AJ; Dahlgren C
    Biochem Pharmacol; 2011 Feb; 81(3):402-11. PubMed ID: 21095183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure.
    Marques PE; Amaral SS; Pires DA; Nogueira LL; Soriani FM; Lima BH; Lopes GA; Russo RC; Avila TV; Melgaço JG; Oliveira AG; Pinto MA; Lima CX; De Paula AM; Cara DC; Leite MF; Teixeira MM; Menezes GB
    Hepatology; 2012 Nov; 56(5):1971-82. PubMed ID: 22532075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential impacts of formyl peptide receptor 1 in inflammatory diseases.
    Yang SC; Hwang TL
    Front Biosci (Elite Ed); 2016 Jun; 8(3):436-49. PubMed ID: 27100350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.